News

Insights on Cohen & Steers Total Return Realty Fund's Distributions

Insights on Cohen & Steers Total Return Realty Fund's Distributions

Understanding Distribution Sources of Cohen & Steers Fund

The Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) provides an important update to its shareholders regarding the sources of distribution. This information pertains to the distribution scheduled to be paid soon and cumulative distributions within the fiscal year. Understanding these sources can help shareholders make informed investment decisions.

The Managed Distribution Policy Explained

This fund adopted a managed distribution policy back in 2011, aiming to support shareholder interests through consistent monthly distributions at a fixed rate per share. This approach allows the Fund flexibility in managing long-term capital gains while ensuring these gains are distributed monthly. Such flexibility may influence the market price of the Fund's shares as the Board of Directors has the authority to modify or suspend the policy anytime.

Types of Distributions and Their Implications

The Fund's monthly distributions can consist of several financial elements, including long-term capital gains, short-term capital gains, and net investment income. For federal income tax considerations, a return of capital reflects distributions that surpass the net investment income and realized capital gains. It’s essential to note that such returns are not subject to taxation at the time of receipt but may reduce the shareholder's tax basis in their shares.

Monitoring Distribution Details

Shareholders can keep abreast of any distribution updates by visiting the fund's official website or receiving notices directly. However, final tax characteristics for any distributions will ultimately be provided on Form 1099-DIV, delivered after the fiscal year concludes. The specifics of the sources and amounts of distributions may undergo adjustments, emphasizing the importance of tracking these metrics for accurate tax reporting.

Distribution Estimates and Performance Metrics

The following outlines the estimated distribution amounts for February 2025 and the cumulative distributions for the fiscal year, all listed per share:

February 2025 Distribution Estimates

As of February 2025, the total current distribution is estimated at $0.0800 per share, aligning with 100% of the current distribution percentage. The cumulative amount paid year-to-date stands at $0.1600 per share, indicative of significant performance metrics for shareholders to consider.

Breakdown of Distribution Sources

1. Net Investment Income: $0.0205 (25.63%)
2. Net Realized Short-Term Capital Gains: $0.0062 (7.75%)
3. Net Realized Long-Term Capital Gains: $0.0533 (66.62%)
4. Return of Capital: $0.0000 (0.00%)

Evaluating Fund Performance

Investors should also take a close look at the cumulative total return of the Fund for the current fiscal year. The Cumulative Total Return, calculated from January 1, 2025, through January 31, 2025, is reported at 0.77%. Comparatively, the Cumulative Distribution Rate sits at 1.37%, showcasing the Fund's performance alongside its distribution capabilities.

Long-Term Investment Considerations

For a more comprehensive view, the average annual total returns over the past five years reveal a 4.28% growth, which is complemented by a current annualized distribution rate of 8.25%. This data underscores the importance of considering both investment performance and distribution returns when making investment decisions.

Final Notes for Investors

Investors are encouraged to carefully review all information regarding the investment objectives, risks, expenses, and charges before engaging with the Fund. Periodic reports and regulatory filings provide critical insights into the Fund's performance, and shareholders can access these by consulting a financial advisor or the fund's official website. It is imperative to utilize the information available wisely and monitor how it influences personal tax filings.

Frequently Asked Questions

What is the managed distribution policy?

The managed distribution policy allows the Fund to provide consistent monthly distributions, enhancing shareholder returns while maintaining flexibility in capital management.

What should investors consider regarding distributions?

Investors should consider the nature of the distributions, their tax implications, and how they impact the overall investment performance of the Fund.

How are distributions reported for tax purposes?

Distributions will be provided on Form 1099-DIV after the end of the year, detailing how to report them for federal income tax reporting.

What are the recent performance indicators of the Fund?

The Fund has reported a Year-to-date Cumulative Total Return of 0.77% and a Cumulative Distribution Rate of 1.37% as key performance indicators.

Where can shareholders find more information?

Shareholders can access information about the Fund through its official website and periodic reports, which detail performance metrics and financial disclosures.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ensign Group Faces Securities Fraud Action: Key Dates

Updated Category News Views 7

A Tough Spot for Ensign Group Nobody likes getting soaked in a downpour without an umbrella and that's how investors in The Ensign Group, Inc. (NASDAQ: ENSG) must feel right now. Heading straight to court, the company found itself in hot water because of a securities fraud class action that's dragged it down by a hefty 8.2%. A plunge, my friends, investors never wanted to...

Continue Reading
Compass Hit by Securities Fraud Suit; Investor Action Urged

Updated Category News Views 3

Trouble Brewing for Compass Investors Amidst Legal Storm In the tangled web of mergers and acquisitions, Compass, Inc. (NYSE: COMP) finds itself in a legal quagmire that has investors on edge. The stark reality of a securities fraud class action lawsuit has emerged, centered around Compass’s January 2026 merger with Anywhere Real Estate Inc. The Heart of the Allegations...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 7

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
ASUS Unveils NVIDIA HGX AI Systems at GTC Berlin

Updated Category News Views 3

A Shake-Up in AI Infrastructure: ASUS Steps In Who's ready for a seismic shift in AI tech? ASUS popped out the gate with a big reveal at the NVIDIA GTC Berlin 2026, showcasing its new arsenal of AI systems built on NVIDIA's HGX Rubin NVL8. These aren't your average rigs either; they're set to hit the market in Q4 2026 with configurations that cater to everything from AI...

Continue Reading
Shrieve Chemicals Expands Reach with RSG Acquisition

Updated Category News Views 7

Charting a New Course with an Acquisition Here we go again with another business shuffle—Shrieve Chemical Company has snatched up Research Solutions Group. What's cooking here is a classic recipe of expansion and strategic positioning. If you’re not familiar with Shrieve, they’re a big player in the global distribution of specialized chemicals. They've teamed up...

Continue Reading
Advancing Mental Health in NICU Families: 2026 Event Insight

Updated Category News Views 6

Addressing Critical Needs: Hand to Hold's Mission Now, I don't know about you, but when I hear "NICU," my mind goes straight to the intense pressure and emotional rollercoaster that it signifies for families. Hand to Hold, a nonprofit that’s knee-deep in supporting NICU families, isn’t just sitting on their hands. They're hosting a 2026 National NICU Mental Health...

Continue Reading
TeamLogic IT Celebrates Franchise Triumphs at Summit

Updated Category News Views 4

A Vibrant Gathering of IT Luminaries In a bustling corner of Mission Viejo, California, TeamLogic IT brought together its hive of tech-savvy franchisees and industry bigwigs for the annual Owners Summit. For the tech crowd, this wasn't just another rundown hotel conference — it was a vibrant celebration and brainstorming bonanza, all wrapped into one energizing week....

Continue Reading
OUTFRONT Media Gears Up for Q3 2026 Earnings Reveal

Updated Category News Views 5

OUTFRONT Media’s Earnings Drumroll Heading toward that red-letter date of November 5, OUTFRONT Media (NYSE: OUT) has got its ducks in a row. They're ready to spill the beans on third-quarter numbers after close of market—just as clocks hit 4:30 p.m. Eastern. It’s showtime, folks. What’s at Stake? We're talking OUTFRONT Media—one of the big kahunas in out-of-home...

Continue Reading
Fresenius Revamps U.S. Kidney Care with multiFiltratePRO

Updated Category News Views 5

Fresenius Takes a Giant Leap in Kidney Care Fresenius Medical Care is breaking new ground in the U.S., marking a significant milestone with the introduction of the multiFiltratePRO System for critically ill patients battling acute kidney injury (AKI). This isn't some run-of-the-mill equipment upgrade. It's an evolution in how critical care teams manage continuous kidney...

Continue Reading
ICEYE's Wildfire Intelligence: A Game-Changer with OroraTech

Updated Category News Views 1

Wildfire Intelligence Gets a Boost from Space If you think keeping tabs on wildfires is just another task for dusty old fire towers, think again. The satellite game is changing up the field in a monumental way with ICEYE and OroraTech teaming up to bring a sharper eye to wildfire monitoring. With the integration of ICEYE’s SAR (Synthetic Aperture Radar) capabilities and...

Continue Reading

Top 5 Most Recently Viewed Articles

CROSS Protocol Secures $10M with Innovative Public Offering

Updated Category News Views 199

CROSS Protocol Secures $10 Million in Private Token Sale CROSS Protocol, a pioneer in the blockchain gaming industry, has achieved a significant milestone by securing $10 million in a private token sale. This landmark funding effort also introduces a revolutionary equal pricing model designed to benefit all investors uniformly. Details of the Token Sale In total, CROSS...

Continue Reading
Experience the Silence: Slotozilla's New Interactive Project

Updated Category News Views 216

Introducing Slotozilla's Unique Project on Silence Slotozilla, a central platform for online gaming insights and storytelling, is excited to unveil its latest venture: "The Power of Silence." This innovative experience invites individuals to ponder the consequences of a world suddenly devoid of speech, highlighting the essential nature of communication. A World Without...

Continue Reading
Innovative Partnership to Enhance Global Drug Development Success

Updated Category News Views 219

Strategic Alliance Enhancing Drug Development Radyus Research and Eurofins CDMO Alphora have forged a strategic partnership aiming to accelerate early-stage drug development for biotech firms around the globe. With Radyus based in the U.S. and Eurofins CDMO Alphora in Canada, the collaboration seeks to harness their strengths in operational research and development. A...

Continue Reading
Insights on Women's Health: Menopause and Its Persistent Effects

Updated Category News Views 306

Understanding the Struggles Women Face After Menopause Managing health during different stages of menopause can be quite challenging for many women. Recent survey findings provide significant insight into the common symptoms and healthcare experiences associated with peri-menopause, menopause, and post-menopause. Nature's Bounty, a brand known for its commitment to...

Continue Reading
Navigating 2025's Market Trends: Winners and Losers Unpacked

Updated Category News Views 108

Unveiling the Market Dynamics of 2025 As we journey through 2025, I've taken a closer look at the market's ebb and flow, examining what I refer to as the "real report card" for the year. The findings are nothing short of intriguing. Highlighting the Market Stars Among the most notable performers in the tech sector, stocks like Coinbase (COIN) are experiencing impressive...

Continue Reading